Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
PfizerPFE |
$13M |
 |
AstrazenecaAZN |
-$480,000 |
 |
Johnson & JohnsonJNJ |
-$631M |
 |
ModernaMRNA |
-$1.8B |
 |
AbbVieABBV |
-$378M |
Are Apimeds Pharmaceuticals Insiders Buying or Selling?
Apimeds Pharmaceuticals (APUS) has had no reported insider transactions in the past 90 days. The most recent was Christopher Kim, who bought 7,730 shares at $1.86 on May 14, 2025.
Insider trading patterns can signal confidence or concern from the people who know the company best. AltIndex tracks insider transactions as one of 25+ alternative data signals in the APUS AI Score. For government officials trading this stock, see APUS congressional trading.
Who’s Trading Apimeds Pharmaceuticals Stock?
| Insider | Activity | Trades | Last Trade |
|---|---|---|---|
| Inc. Inscobee | Bought $2M | 1 | May 12, 2025 |
| Jakap Koo | Bought $57,000 | 1 | May 12, 2025 |
| Christopher Kim | Bought $50,000 | 2 | May 14, 2025 |
Recent Apimeds Pharmaceuticals Insider Transactions
| Insider | Transaction Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Christopher Kim | May 14, 2025 | Buy | 7,730 | $1.86 | $14,000 |
| Christopher Kim | May 13, 2025 | Buy | 19,770 | $1.82 | $36,000 |
| Inc. Inscobee | May 12, 2025 | Buy | 500,000 | $4 | $2M |
| Jakap Koo | May 12, 2025 | Buy | 28,500 | $1.99 | $57,000 |
Frequently Asked Questions: Apimeds Pharmaceuticals Insider Trading
Apimeds Pharmaceuticals insiders have not reported any transactions in the past 90 days.
Insider buying is generally a stronger signal than insider selling, since insiders may sell for personal reasons (diversification, taxes) but typically buy only when they believe the stock is undervalued. AltIndex uses insider transaction patterns alongside 25+ other signals in the AI Score.
Inscobee Inc. has bought the most APUS stock in the last 2 years, with a total value of $2M.
According to our estimates, the total value of insider transactions for Apimeds Pharmaceuticals in the last 2 years is positive, amounting to $2.1M. This indicates that insiders have predominantly bought shares, showcasing their confidence in the company's future prospects.
